I TUOI DATI
I TUOI ORDINI
N. prodotti: 0
Totale ordine: € 0,00
I TUOI ABBONAMENTI
I TUOI ARTICOLI
EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE
Rivista di Medicina Fisica e Riabilitativa dopo Eventi Patologici
Official Journal of the , , , ,
In association with
Indexed/Abstracted in: CINAHL, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,063
European Journal of Physical and Rehabilitation Medicine 2016 Mar 22
Can pelvic floor muscle training improve quality of life in men with mild to moderate post-stroke and lower urinary tract symptoms? A randomised, controlled and single-blinded trial
Sigrid TIBAEK, Gunvor GARD, Christian DEHLENDORFF, Helle IVERSEN, Fin BIERING-SOERENSEN, Rigmor JENSEN ✉
Department of Occupational Therapy and Physiotherapy, Rigshospitale, Glostrup, Denmark
BACKGROUND: Lower urinary tract symptoms (LUTS) have a significant impact on quality of life (QoL) in post-stroke patients.
AIM: To evaluate the effect of pelvic floor muscle training (PFMT) on QoL parameters in men with post-stroke LUTS.
DESIGN: Randomised, controlled and single-blinded trial.
SETTING: Outpatients, University Hospital.
POPULATION: Thirty-one men, median age 68 (interquartile range 60 - 74) years, with post-stroke LUTS were included. Thirty participants completed the study.
METHODS: The participants randomised to the treatment group were treated in a systematic, controlled and intensive PFMT programme over 3 months (12 weekly sessions). The participants randomised to the control group did not receive specific LUTS treatment. The effect was measured on the 36-Item Short Form Health Survey (SF-36) and the Nocturia Quality-of-Life (N-QoL) Questionnaire.
RESULTS: The results on SF-36 indicated significant improvement within pre- and post- test in the domains emotional role (median 77 to 100, P = 0.03) and vitality (median 65 to 70, P = 0.03) in the treatment group, but not the control group. There were no statistically significant differences between groups at pre-test, post-test or 6-month follow-up. The results on N-QoL indicated statistically significant differences between pre- and post-test in the bother/concern domain in both groups and in sleep/energy for the control group, but not the treatment group. There were no statistically significant differences between groups.
CONCLUSIONS: PFMT may improve the emotional health and vitality domains of QoL in men with mild to moderate post-stroke and LUTS; however the improvements in the treatment group were not significantly better than for the control group. PFMT did not improve nocturia-related QoL.
CLINICAL REHABILITATION IMPACT: This study is the first to evaluate the effect of PFMT on QoL parameters in men with mild to moderate post-stroke and LUTS. The results indicate some short-term effect on SF-36 but none on N-QoL. However, further studies with larger sample sizes and with less restrictive inclusion and exclusion criteria are requested.